Youmanitarian
Youmanitarian 11 Jun 2021

Up next

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 13 Views

Defining Progression in Metastatic Kidney Cancer

10 Views
TAKE ACTION
Donations would go to support charities for #HEALTHCARE / Kidney Cancer

Panelists Robert A. Figlin, MD; Michael R. Harrison, MD; David I. Quinn, MBBS, PhD; and Eric Jonasch, MD, discuss defining clinical progression and optimizing use of VEGF TKI therapy to achieve the highest dose intensity before switching in patients with metastatic kidney cancer.

Show more
More ways to take action
Explore ways that you can help bring a solution to this issue.

Up next

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 13 Views